DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sun Pharma Advanced Research Company Limited — Board Meeting Intimation

NSE 1 hr ago·22 Oct 2026, 6:56 am

Sun Pharma Advanced Research Company

Sun Pharma Advanced Research Company Limited (SPARC) has announced that its Board of Directors will meet on November 2, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year 2026-27. This is a standard corporate procedure where the board reviews the company's performance before the results are officially disclosed to the public.

For investors, this announcement is significant as it signals the upcoming release of key financial data. The results will provide a snapshot of SPARC's operational health and profitability during the initial six months of the financial year. Investors will closely watch the revenue growth and margins to gauge the company's trajectory.

What to watch next is the official release of the unaudited financial statements. Market participants will analyze the management commentary accompanying the results to understand the company's outlook and strategy for the remainder of the year.